India.com News Desk | Dec 23, 2020, 11:34 PM IST
Moreover, this vaccine will be much more affordable than existing ones produced by Pfizer (NYSE: PFE) and GlaxoSmithKline (LSE: GSK).
India.com News Desk | Dec 23, 2020, 8:53 AM IST
Coronavirus Vaccine Update: The government committee for vaccine approval is currently going through applications of at least three firms that have sought for emergency use in India.
India.com News Desk | Dec 19, 2020, 8:55 PM IST
It is because when frivolous claims come up, and something is blown out of proportion in the media, skepticism sets in that definitely something can happen due to the vaccine and to dispel that, the government needs to step in to spread the right information, Poonawalla said.
India.com News Desk | Dec 13, 2020, 11:33 AM IST
"By this month-end, we might get an emergency licence [for the coronavirus vaccine], but the actual licence for wider use might come in at a later date. But we are confident that if the regulators give a nod, India's vaccination drive can start by January 2021," Adar Poonawalla said.
India.com News Desk | Dec 9, 2020, 6:36 PM IST
Serum Institute of India had requested the Centre for approval of the Oxford vaccine, Covishield, on December 6. On the other hand, Pfizer also sought approval from India after securing clearances in the UK and Bahrain.
India.com News Desk | Dec 8, 2020, 1:08 PM IST
Serum Institute's COVID-19 Vaccine : The Pune-based SII has collaborated with AstraZeneca and Oxford University for manufacturing the vaccine and is conducting phase-three clinical trials of the Covishield vaccine in India.
India.com News Desk | Dec 5, 2020, 1:02 PM IST
Poonawalla joined the Serum Institute of India in 2001 and became the CEO of Serum Institute with complete control of the day-to-day operations of the company in 2011.
India.com News Desk | Dec 3, 2020, 7:34 AM IST
Last week, the 40-year-old man who was a volunteer in the third phase of the vaccine trial in Chennai claimed to have suffered serious neurological and psychological symptoms after taking the experimental shot.
India.com News Desk | Nov 29, 2020, 9:45 PM IST
SII to Seek 100 cr in Damages From Volunteer Who Said 'Covishield' Vaccine Left Him Unwell
India.com News Desk | Nov 29, 2020, 1:30 AM IST
Poonawalla said that SII is in the process of submitting the data for the clinical trials to the DCGI and will seek emergency use authorisation of the vaccine.
India.com News Desk | Nov 28, 2020, 5:32 PM IST
After landing at Pune airport around 4.30 pm from Hyderabad, Modi proceeded to the Serum Institute of India (SII) by helicopter.
India.com News Desk | Nov 28, 2020, 6:58 AM IST
The Prime Minister is expected to spend around two hours at the Zydus Cadila plant. At around 11:30, he will depart for Pune to the Serum Institute of India.
